Patient Blood Management for the Patient

patient blood management for patients

Patient Blood Management looks after your blood

We are all potential patients. Knowing a few facts about our blood and the latest information on how it should be managed prepares us to ask the right questions to ensure the best possible treatment. If you read all the sections below, you will have a basic knowledge of Patient Blood Management and you will be able to communicate with your doctor effectively about your treatment.

“Our own blood is still the best thing to have in our veins”. Tim Frenzel

Why Your Blood is Important

How to manage the doctor/patient relationship

There are some practical things you can do to manage the doctor/patient relationship.

How to manage the doctor/patient relationship

What your doctor should tell y

Your doctor should make sure you are aware of these important facts.

What your doctor should tell you

Three simple questions to ask your doctor

If you have concerns that you feel have not been answered or addressed already, you have every right to ask these 3 questions.

Three simple questions to ask your doctor

Stay Connected

TWITTER INSTAGRAM

Who is Online?

We have 86 guests and one member online

In simple terms, Patient Blood Management is a multidisciplinary approach to managing the patient’s blood during medical treatment with the aim of improving health outcomes.

The literature identifies three independent risk factors for adverse patient outcomes: anaemia, bleeding and blood transfusion.

These risk factors are modifiable with the application of the “three pillars” of Patient Blood Management:

Optimise erythropoiesis (including red cell mass and iron stores)
Minimise blood loss (surgical) and bleeding (coagulopathic)
Harness and optimize the patient-specific physiological reserve of anaemia while treatment is initiated

In surgical and medical patients the three pillars are applied in three phases:

Before specific treatment
During specific treatment
Following up after specific treatment

This approach can be represented as a nine-field matrix.

Managing the patient’s blood and haemopoietic system is like managing any of the other organs and organs systems during the patient’s care. Specialists manage the heart, the kidneys, the endocrine system, etc. The patient’s blood requires similar clinical management.

The haemopoietic system and its circulatory products are pivotal for the healthy function of the human organism.

The International Foundation for Patient Blood Management is committed to ensuring that this unique and vital human resource is appropriately managed and maintained in health and disease. To this end the Foundation promotes scientifically based medical and surgical Patient Blood Management techniques aimed at conserving a patient’s own blood and minimizing or avoiding the need for the transfusion of allogeneic blood components.

The Foundation acknowledges that altruistically donated allogeneic blood, given in trust, is a valuable community resource. However, it is a costly resource with significant potential for adverse clinical outcomes. Accordingly, it should only be used as therapy with patient consent when there is evidence for potential benefit, there are no alternatives, and the risks are appropriately considered and balanced against the benefits.

In this context the Foundation, as a multidisciplinary organization, is committed to aligning the best medical evidence with ethical and economic considerations that ensure that patient blood management related therapies are appropriately assessed for cost effectiveness, with patients’ choices and blood donors’ trust being respected.